4.7 Review

Recent Advances of Osterix Transcription Factor in Osteoblast Differentiation and Bone Formation

Journal

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fcell.2020.601224

Keywords

osterix; osteoblast differentiation; therapy; osteolytic diseases; bone

Funding

  1. National Natural Science Foundation of China (NSFC) [81670809]
  2. Science and Technology Research Fund of Hunan Provincial Education Department

Ask authors/readers for more resources

With increasing life expectations, more and more patients suffer from fractures either induced by intensive sports or other bone-related diseases. The balance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption is the basis for maintaining bone health. Osterix (Osx) has long been known to be an essential transcription factor for the osteoblast differentiation and bone mineralization. Emerging evidence suggests that Osx not only plays an important role in intramembranous bone formation, but also affects endochondral ossification by participating in the terminal cartilage differentiation. Given its essentiality in skeletal development and bone formation, Osx has become a new research hotspot in recent years. In this review, we focus on the progress of Osx's function and its regulation in osteoblast differentiation and bone mass. And the potential role of Osx in developing new therapeutic strategies for osteolytic diseases was discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available